Cancer-Associated Thrombosis and Bleeding Risk in Gastrointestinal Malignancies with Apixaban and Rivaroxaban Compared to Low Molecular Weight Heparin

被引：1
|
作者：
Houghton, Damon E. [1 ]
Bott-Kitslaar, Dalene M. [1 ]
Vargas, Emily [2 ]
Hodge, David O. [2 ]
Lang, Teresa R. [3 ]
Peterson, Lisa [4 ]
Casanegra, Ana I. [1 ]
McBane, Robert D. [1 ]
Wysokinski, Waldemar E. [1 ]
Froehling, David A. [3 ]
机构：
[1] Mayo Clin, Dept Cardiovasc Dis, Gonda Vasc Ctr, Thrombophilia Clin, Rochester, MN USA
[2] Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL 32224 USA
[3] Gonda Vasc Ctr, Dept Cardiovasc Dis, Thrombophilia Clin, Rochester, MN USA
[4] Mayo Clin, Dept Cardiovasc Dis, Gonda Vasc Ctr, Thrombophilia Clin,Mayo Clin Rochester, Rochester, MN USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-114185
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
362
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study
    Linder, Marie
    Ekbom, Anders
    Brobert, Gunnar
    Vogtlaender, Kai
    Balabanova, Yanina
    Becattini, Cecilia
    Carrier, Marc
    Cohen, Alexander T.
    Coleman, Craig I.
    Khorana, Alok A.
    Lee, Agnes Y. Y.
    Psaroudakis, George
    Abdelgawwad, Khaled
    Rivera, Marcela
    Schaefer, Bernhard
    Giunta, Diego Hernan
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (06) : 973 - 983
  • [42] Direct Oral Anticoagulants Compared With Low Molecular Weight Heparin and Vitamin K Antagonists in the Management of Cancer-Associated Thrombosis: A Systematic Review and Network Meta-Analysis
    Mir, Ali
    Rahman, Mohammed F.
    Ragab, Khaled M.
    Elsayed, Sarah M.
    Fathallah, Ahmed H.
    Hagrass, Abdulrahman I.
    Kamal, Ibrahim
    Farooq, Waseem
    Bahuva, Ronak
    Page, Brian
    CIRCULATION, 2022, 146
  • [43] The Use of Thromboelastography in Monitoring Coagulation Status for Patients Treated with Low Molecular Weight Heparin, Warfarin, Apixaban, and Rivaroxaban
    Jiang, Debbie
    Dumont, Anne
    Burns, Adrienne J.
    Rinder, Henry
    Tormey, Christopher A.
    Lee, Alfred
    BLOOD, 2017, 130
  • [44] Comparative Study between Rivaroxaban and Conventional Low Molecular Weight Heparin Anticoagulant in Preventing Thrombosis
    Zhao, Zhongfu
    Li, Xiaoguang
    Wang, Jin
    Dong, Wei
    Ding, Ling
    Yao, Hongbo
    2013 3RD INTERNATIONAL CONFERENCE ON SOCIAL SCIENCES AND SOCIETY (ICSSS 2013), PT 11, 2013, 42 : 244 - 248
  • [45] Low-molecular weight heparin versus vitamin K antagonists for the treatment of cancer-associated thrombosis: A cost-effectiveness analysis
    Connell, Nathan T.
    Abel, Gregory A.
    Connors, Jean M.
    THROMBOSIS RESEARCH, 2017, 150 : 53 - 58
  • [46] Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study)
    Otero, Remedios
    Solier-Lopez, Aurora
    Sanchez-Lopez, Veronica
    Oto, Julia
    Arellano, Elena
    Marin, Samira
    Jara-Palomares, Luis
    Elias, Teresa
    Asencio, Maria Isabel
    Blasco-Esquivias, Isabel
    Rodriguez de la Borbolla, Maria
    Sanchez-Diaz, Jose Maria
    Real-Dominguez, Macarena
    Garcia-Cabrera, Emilio
    Rodriguez-Martorell, Francisco Javier
    Medina, Pilar
    CANCERS, 2022, 14 (11)
  • [47] Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosis
    Kang, Wei
    Huang, Caige
    Yan, Vincent K. C.
    Wei, Yue
    Shami, Jessica J. P.
    Li, Silvia T. H.
    Yang, Yu
    Ye, Xuxiao
    Tang, Junhan
    Lee, Shing Fung
    Lee, Victor H. F.
    Chan, Stephen L.
    El Helali, Aya
    Lam, Ka On
    Ngan, Roger K. C.
    Wong, Ian C. K.
    Chan, Esther W.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [48] Gastrointestinal Disorders and Toxicities Induced By Anticancer Drugs. Another Risk Factor of Bleeding in Cancer-Associated Thrombosis
    Janus, Nicolas
    BLOOD, 2020, 136
  • [49] Direct oral anticoagulants compared to low-molecular-weight heparin for the treatment of cancer-associated thrombosis: Updated systematic review and meta-analysis of randomized controlled trials
    Moik, Florian
    Posch, Florian
    Zielinski, Christoph
    Pabinger, Ingrid
    Ay, Cihan
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (04) : 550 - 561
  • [50] Bleeding risk with fixed dose subcutaneous low molecular weight heparin compared to intravenous adjusted dose unfractionated heparin: a metanalysis
    Podda, G.
    Costantino, G.
    Ceriani, E.
    Rusconi, A.
    Casazza, G.
    Montano, N.
    Duca, P.
    Cattaneo, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 269 - 269
12345